Arcus Biosciences Inc (NYSE:RCUS)
$ 16.05 0.05 (0.31%) Market Cap: 1.46 Bil Enterprise Value: 471.25 Mil PE Ratio: 0 PB Ratio: 2.06 GF Score: 75/100

Arcus Biosciences Inc at Citi Virtual Oncology Leadership Summit Transcript

Feb 21, 2023 / 06:00PM GMT
Release Date Price: $18.58 (-8.52%)
Yigal Dov Nochomovitz
Citigroup Inc. Exchange Research - Research Analyst

Okay. Great. Welcome, everyone. I'm Yigal Nochomovitz, one of the biotech analysts here at Citi. Welcome back to the Citi Oncology Summit in the first quarter of the year. So it's my pleasure to have with me senior management from Arcus, Terry Rosen, the CEO; and Juan Jaen, President. So gentlemen, welcome. Thank you so much for taking a few minutes to chat. Really appreciate it.

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

Thanks Yigal.

Yigal Dov Nochomovitz
Citigroup Inc. Exchange Research - Research Analyst

Sure. I think everyone is obviously super familiar with you guys given the debate in the TIGIT space. But nonetheless, it would be helpful if you could -- Terry, if you could just kind of level set kind of give us the quick overview of the pipeline and what are the key upcoming catalysts that people need to be aware of and just at a high level, how you -- how Arcus approaches drug development differently

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot